Share class: Alkem Laboratories Limited

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 119,565,000 44,349,446 ( 37.09 %) 0 37.09 %

Major shareholders: Alkem Laboratories Limited

NameEquities%Valuation
18.81 %
22,493,888 18.81 % 1 281 M ₹
7.272 %
8,695,360 7.272 % 495 M ₹
6.425 %
7,682,000 6.425 % 437 M ₹
6.184 %
7,393,939 6.184 % 421 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
4.215 %
5,039,791 4.215 % 287 M ₹
2.821 %
3,373,312 2.821 % 192 M ₹
SBI Funds Management Ltd. (Investment Management)
2.414 %
2,886,710 2.414 % 164 M ₹
2.312 %
2,764,719 2.312 % 157 M ₹
2.248 %
2,688,000 2.248 % 153 M ₹
2.157 %
2,579,045 2.157 % 147 M ₹
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Individuals62.59%
Institutional16.82%
Other1.39%
Unknown19.2%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
62.59%
India
17.42%
Singapore
0.46%
United Kingdom
0.16%
Sweden
0.09%
Netherlands
0.03%
Ireland
0.03%
Japan
0.01%
Switzerland
0.01%

Based on 1000 largest holdings

Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
18,785